ArticleCancer communications (London, England)2025

Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma.

Jinghan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.